Gaby Danan

4.5k total citations · 3 hit papers
61 papers, 3.3k citations indexed

About

Gaby Danan is a scholar working on Pharmacology, Hepatology and Toxicology. According to data from OpenAlex, Gaby Danan has authored 61 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pharmacology, 15 papers in Hepatology and 13 papers in Toxicology. Recurrent topics in Gaby Danan's work include Drug-Induced Hepatotoxicity and Protection (40 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacovigilance and Adverse Drug Reactions (13 papers). Gaby Danan is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (40 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacovigilance and Adverse Drug Reactions (13 papers). Gaby Danan collaborates with scholars based in Germany, France and Netherlands. Gaby Danan's co-authors include C Bénichou, Rolf Teschke, Antoine Flahault, Dominique Pessayre, Benhamou Jp, Véronique Descatoire, Dominique Larrey, Axel Eickhoff, Johannes Schulze and Dieter Melchart and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Gaby Danan

58 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries

1993 1.1k citations Gaby Danan, C Bénichou Journal of Clinical Epidemiology profile →
RUCAM in Drug and Herb Induced Liver Injury: The Update

2015 552 citations Gaby Danan, Rolf Teschke International Journal of Molecular Sciences profile →
Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge

1993 433 citations C Bénichou, Gaby Danan et al. Journal of Clinical Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gaby Danan Germany	22	2.5k	780	731	640	385	61	3.3k
C Bénichou France	11	2.0k 0.8×	614 0.8×	676 0.9×	510 0.8×	363 0.9×	34	2.6k
Victor J. Navarro United States	35	2.9k 1.1×	1.5k 1.9×	764 1.0×	1.3k 2.1×	401 1.0×	128	5.3k
George Ostapowicz United States	12	2.3k 0.9×	1.4k 1.8×	479 0.7×	1.8k 2.9×	272 0.7×	22	3.8k
Andrew Stolz United States	34	1.6k 0.6×	788 1.0×	986 1.3×	516 0.8×	486 1.3×	97	3.6k
Miren García‐Cortés Spain	18	1.3k 0.5×	465 0.6×	378 0.5×	340 0.5×	204 0.5×	55	1.8k
Jiezhun Gu United States	25	1.4k 0.6×	703 0.9×	493 0.7×	626 1.0×	199 0.5×	55	2.2k
Christine M. Hunt United States	28	1.0k 0.4×	1.5k 1.9×	419 0.6×	1.3k 2.1×	225 0.6×	75	3.1k
J. Michael Tredger United Kingdom	31	1.1k 0.4×	432 0.6×	403 0.6×	732 1.1×	400 1.0×	109	2.9k
M. Isabel Lucena Spain	45	5.2k 2.1×	2.0k 2.6×	1.7k 2.3×	1.6k 2.6×	685 1.8×	195	7.4k
Julie Polson United States	10	1.7k 0.7×	1.0k 1.3×	331 0.5×	1.6k 2.4×	169 0.4×	14	2.9k

Countries citing papers authored by Gaby Danan

Since Specialization

Citations

This map shows the geographic impact of Gaby Danan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaby Danan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaby Danan more than expected).

Fields of papers citing papers by Gaby Danan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaby Danan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaby Danan. The network helps show where Gaby Danan may publish in the future.

Co-authorship network of co-authors of Gaby Danan

This figure shows the co-authorship network connecting the top 25 collaborators of Gaby Danan. A scholar is included among the top collaborators of Gaby Danan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaby Danan. Gaby Danan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teschke, Rolf & Gaby Danan. (2024). Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method. SHILAP Revista de lepidopterología. 11(4). 9–9. 6 indexed citations

Teschke, Rolf & Gaby Danan. (2023). Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use. International Journal of Molecular Sciences. 24(13). 10855–10855. 11 indexed citations

Teschke, Rolf, Axel Eickhoff, Johannes Schulze, & Gaby Danan. (2021). Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview. Translational Gastroenterology and Hepatology. 6. 51–51. 27 indexed citations

Teschke, Rolf & Gaby Danan. (2020). Liver Injury by Drugs Metabolized via Cytochrome P450. 8(1). 93–98. 7 indexed citations

Danan, Gaby & Rolf Teschke. (2019). Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future. Frontiers in Pharmacology. 10. 853–853. 86 indexed citations

Danan, Gaby & Rolf Teschke. (2018). Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?. Drug Safety. 41(8). 735–743. 66 indexed citations

Teschke, Rolf, Albrecht Wolff, Axel Eickhoff, & Gaby Danan. (2018). Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury?. JGH Open. 2(4). 152–157. 7 indexed citations

Teschke, Rolf & Gaby Danan. (2017). Drug-induced liver injury, mortality, and liver transplantation: is it reasonable to use a global introspection causality assessment?. AME Medical Journal. 2. 144–144. 3 indexed citations

Teschke, Rolf & Gaby Danan. (2016). Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease. Drug Safety. 39(8). 729–744. 40 indexed citations

10.

Danan, Gaby & Rolf Teschke. (2015). RUCAM in Drug and Herb Induced Liver Injury: The Update. International Journal of Molecular Sciences. 17(1). 14–14. 552 indexed citations breakdown →

11.

Edwards, I. Ralph, Gaby Danan, Cecilia Biriell, & C Bénichou. (1993). Proposed improvement to the WHO adverse reaction terminology (WHO‐ART). Pharmacoepidemiology and Drug Safety. 2(3). 177–184. 2 indexed citations

12.

Danan, Gaby & C Bénichou. (1993). Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. Journal of Clinical Epidemiology. 46(11). 1323–1330. 1122 indexed citations breakdown →

13.

Bénichou, C, Gaby Danan, & Antoine Flahault. (1993). Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. Journal of Clinical Epidemiology. 46(11). 1331–1336. 433 indexed citations breakdown →

14.

Danan, Gaby. (1991). Définitions et critères d'imputation des atteintes hépatiques aiguës médicamenteuses. Conclusions d'une réunion internationale de consensus.. Gastroentérologie Clinique et Biologique. 15(11). 8 indexed citations

15.

Bénichou, C, et al.. (1989). [Management of clinical or biological abnormalities during therapeutic trials].. PubMed. 43(6). 465–8. 1 indexed citations

16.

Danan, Gaby. (1988). Consensus meetings on: Causality assessment of drug-induced liver injury. Journal of Hepatology. 7(1). 132–136. 56 indexed citations

17.

Lefébure, B., et al.. (1984). Hépatites aux antidépresseurs. Bilan des observations de l'Association Française des Centres de Phamacovigilance et de la Commission Technique.. Therapies. 39(5). 3 indexed citations

18.

Larrey, Dominique, B Rueff, Gérard Feldmann, et al.. (1984). Recurrent jaundice caused by recurrent hyperemesis gravidarum.. Gut. 25(12). 1414–1415. 27 indexed citations

19.

Danan, Gaby, Véronique Descatoire, & Dominique Pessayre. (1981). Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450.. Journal of Pharmacology and Experimental Therapeutics. 218(2). 509–514. 78 indexed citations

20.

Ganeval, D, et al.. (1978). [Fatal cardiac arrhythmia during treatment with cimetidine].. PubMed. 7(23). 2069–2069. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact